JP2009533025A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009533025A5 JP2009533025A5 JP2009504346A JP2009504346A JP2009533025A5 JP 2009533025 A5 JP2009533025 A5 JP 2009533025A5 JP 2009504346 A JP2009504346 A JP 2009504346A JP 2009504346 A JP2009504346 A JP 2009504346A JP 2009533025 A5 JP2009533025 A5 JP 2009533025A5
- Authority
- JP
- Japan
- Prior art keywords
- dendritic
- dendritic cell
- cells
- dendritic cells
- ifn
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004443 dendritic cell Anatomy 0.000 claims 35
- 238000000034 method Methods 0.000 claims 15
- 108091032973 (ribonucleotides)n+m Proteins 0.000 claims 9
- 108010029697 CD40 Ligand Proteins 0.000 claims 9
- 102100032937 CD40 ligand Human genes 0.000 claims 9
- 239000000556 agonist Substances 0.000 claims 6
- 239000000427 antigen Substances 0.000 claims 5
- 102000036639 antigens Human genes 0.000 claims 5
- 108091007433 antigens Proteins 0.000 claims 5
- 108010085650 interferon gamma receptor Proteins 0.000 claims 5
- 229960005486 vaccine Drugs 0.000 claims 5
- 108020004707 nucleic acids Proteins 0.000 claims 4
- 102000039446 nucleic acids Human genes 0.000 claims 4
- 150000007523 nucleic acids Chemical class 0.000 claims 4
- 230000011664 signaling Effects 0.000 claims 4
- MZOFCQQQCNRIBI-VMXHOPILSA-N (3s)-4-[[(2s)-1-[[(2s)-1-[[(1s)-1-carboxy-2-hydroxyethyl]amino]-4-methyl-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-3-[[2-[[(2s)-2,6-diaminohexanoyl]amino]acetyl]amino]-4-oxobutanoic acid Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCCN=C(N)N)NC(=O)[C@H](CC(O)=O)NC(=O)CNC(=O)[C@@H](N)CCCCN MZOFCQQQCNRIBI-VMXHOPILSA-N 0.000 claims 3
- 102100037850 Interferon gamma Human genes 0.000 claims 3
- 108010074328 Interferon-gamma Proteins 0.000 claims 3
- 108060008682 Tumor Necrosis Factor Proteins 0.000 claims 3
- 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 claims 3
- 125000000539 amino acid group Chemical group 0.000 claims 3
- 210000004027 cell Anatomy 0.000 claims 3
- DDOVBCWVTOHGCU-QMXMISKISA-N n-[(e,2s,3r)-3-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxynonadec-4-en-2-yl]octadecanamide Chemical compound CCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)\C=C\CCCCCCCCCCCCCC)CO[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O DDOVBCWVTOHGCU-QMXMISKISA-N 0.000 claims 3
- VQFKFAKEUMHBLV-BYSUZVQFSA-N 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine Chemical group CCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@H]([C@H](O)[C@H](O)CCCCCCCCCCCCCC)CO[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQFKFAKEUMHBLV-BYSUZVQFSA-N 0.000 claims 2
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 2
- 102100036301 C-C chemokine receptor type 7 Human genes 0.000 claims 2
- 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 claims 2
- 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 claims 2
- 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 claims 2
- 210000001744 T-lymphocyte Anatomy 0.000 claims 2
- 150000001875 compounds Chemical class 0.000 claims 2
- 210000003162 effector t lymphocyte Anatomy 0.000 claims 2
- 238000000338 in vitro Methods 0.000 claims 2
- 210000003071 memory t lymphocyte Anatomy 0.000 claims 2
- GOJUJUVQIVIZAV-UHFFFAOYSA-N 2-amino-4,6-dichloropyrimidine-5-carbaldehyde Chemical group NC1=NC(Cl)=C(C=O)C(Cl)=N1 GOJUJUVQIVIZAV-UHFFFAOYSA-N 0.000 claims 1
- HOMYIYLRRDTKAA-UHFFFAOYSA-N 2-hydroxy-N-[3-hydroxy-1-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoctadeca-4,8-dien-2-yl]hexadecanamide Chemical compound CCCCCCCCCCCCCCC(O)C(=O)NC(C(O)C=CCCC=CCCCCCCCCC)COC1OC(CO)C(O)C(O)C1O HOMYIYLRRDTKAA-UHFFFAOYSA-N 0.000 claims 1
- 241001385733 Aesculus indica Species 0.000 claims 1
- 108020004705 Codon Proteins 0.000 claims 1
- 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 claims 1
- 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 claims 1
- 108090000978 Interleukin-4 Proteins 0.000 claims 1
- 241000269435 Rana <genus> Species 0.000 claims 1
- MYYARUCLXARAEE-ZATZPJRKSA-N alpha-C-GalCer Chemical compound CCCCCCCCCCCCCCCCCCCCCCCCCCC(=O)N[C@@H](CC[C@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O)[C@H](O)[C@H](O)CCCCCCCCCCCCCCCCC MYYARUCLXARAEE-ZATZPJRKSA-N 0.000 claims 1
- 230000003796 beauty Effects 0.000 claims 1
- 239000002299 complementary DNA Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 108020004999 messenger RNA Proteins 0.000 claims 1
- 229920001184 polypeptide Polymers 0.000 claims 1
- 102000004196 processed proteins & peptides Human genes 0.000 claims 1
- 108090000765 processed proteins & peptides Proteins 0.000 claims 1
- 238000001890 transfection Methods 0.000 claims 1
- 230000001052 transient effect Effects 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US11/400,774 US8513008B2 (en) | 2004-10-07 | 2006-04-07 | Mature dendritic cell compositions and methods for culturing same |
| US11/400,774 | 2006-04-07 | ||
| PCT/US2007/008734 WO2007117682A2 (en) | 2006-04-07 | 2007-04-06 | Mature dendritic cell compositions and methods for culturing same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009533025A JP2009533025A (ja) | 2009-09-17 |
| JP2009533025A5 true JP2009533025A5 (enExample) | 2010-05-20 |
| JP5425618B2 JP5425618B2 (ja) | 2014-02-26 |
Family
ID=38581685
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009504346A Expired - Fee Related JP5425618B2 (ja) | 2006-04-07 | 2007-04-06 | 成熟樹状細胞組成物およびそれを培養するための方法 |
Country Status (10)
| Country | Link |
|---|---|
| US (4) | US8513008B2 (enExample) |
| EP (1) | EP2003969B1 (enExample) |
| JP (1) | JP5425618B2 (enExample) |
| KR (1) | KR101425686B1 (enExample) |
| CN (1) | CN101460054B (enExample) |
| AT (1) | ATE510451T1 (enExample) |
| AU (1) | AU2007235227B2 (enExample) |
| CA (1) | CA2648675C (enExample) |
| DK (1) | DK2003969T3 (enExample) |
| WO (1) | WO2007117682A2 (enExample) |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8513008B2 (en) | 2004-10-07 | 2013-08-20 | Argos Therapeutics, Inc. | Mature dendritic cell compositions and methods for culturing same |
| KR101243577B1 (ko) | 2004-10-07 | 2013-03-20 | 아고스 쎄라퓨틱스, 인코포레이티드 | 성숙 수지상 세포 조성물 및 그의 배양 방법 |
| JP5020935B2 (ja) | 2005-04-08 | 2012-09-05 | アルゴス セラピューティクス,インコーポレイティド | 樹状細胞組成物および方法 |
| ES2520026T3 (es) | 2006-09-18 | 2014-11-11 | The Board Of Trustees Of The University Of Arkansas | Composiciones y métodos para potenciar respuestas inmunitarias |
| WO2009039198A2 (en) * | 2007-09-17 | 2009-03-26 | The Trustees Of The University Of Pennsylvania | Generation of hyperstable mrnas |
| BRPI0818736A2 (pt) * | 2007-10-30 | 2017-06-13 | Univ Arkansas | composições e métodos para intensificar imunorrepostas à bactéria flagelada |
| CN101969990B (zh) | 2007-11-01 | 2014-07-09 | 阿肯色大学评议会 | 增强针对艾美球虫属的免疫反应的组合物和方法 |
| EP2072617A1 (en) * | 2007-12-12 | 2009-06-24 | Trimed Biotech GmbH | Method for producing dendritic cells |
| EP2254998B1 (en) * | 2008-02-28 | 2015-12-23 | Argos Therapeutics, Inc. | Transient expression of immunomodulatory polypeptides for the prevention and treatment of autoimmune disease, allergy and transplant rejection |
| CN102811734B (zh) | 2010-01-21 | 2016-02-10 | 阿肯色大学评议会 | 增强免疫应答的疫苗载体和方法 |
| CN102971008B (zh) | 2010-06-09 | 2015-11-25 | 阿肯色大学评议会 | 降低弯曲菌属感染的疫苗和方法 |
| WO2012041635A1 (en) * | 2010-09-29 | 2012-04-05 | Universite De Liege | Combination of an agonistic anti-cd40 monoclonal antibody or a cd40 ligand and inactivated or attenuated bacteria for use in the treatment and/or prevention of mastitis |
| CN109536446B (zh) * | 2012-02-10 | 2022-08-02 | 医疗法人社团博心厚生会 | 单核细胞增殖剂、单核细胞增殖用培养基、及单核细胞的制造方法 |
| US9603915B2 (en) | 2013-02-14 | 2017-03-28 | The Board of Trustees of the University of Akansas | Compositions and methods of enhancing immune responses to Eimeria or limiting Eimeria infection |
| BR112015023024B1 (pt) | 2013-03-15 | 2022-04-19 | The Board Of Trustees Of The University Of Arkansas | Vetor de vacina e composições farmacêuticas compreendendo o mesmo |
| AU2015218865B2 (en) * | 2014-02-21 | 2021-06-10 | Coimmune, Inc. | TSCM cells and methods for use |
| EP3316897A4 (en) | 2015-07-02 | 2019-03-13 | Primevax Immuno-Oncology, Inc. | COMPOSITIONS AND METHODS FOR COMBINATION THERAPY WITH DENGUE VIRUS AND DENDRITIC CELLS |
| JP2018535191A (ja) * | 2015-09-26 | 2018-11-29 | プライムヴァックス イミュノ−オンコロジー,インク. | 樹状細胞を産生するための組成物及び方法 |
| WO2017102010A1 (en) * | 2015-12-17 | 2017-06-22 | Biontech Rna Pharmaceuticals Gmbh | Novel cytokine fusion proteins |
| WO2017123242A1 (en) * | 2016-01-15 | 2017-07-20 | Ding Enyu | A universal nucleic acid drug vector enhancing mrna stability and translatability |
| KR102767638B1 (ko) | 2016-05-03 | 2025-02-20 | 더 보드 오브 트러스티스 오브 더 유니버시티 오브 아칸소 | 면역자극 및 항원 폴리펩티드를 포함하는 효모 백신 벡터, 및 그를 이용하는 방법 |
| JP2020500847A (ja) | 2016-11-16 | 2020-01-16 | プライムヴァックス イミュノ−オンコロジー,インク. | 癌の処置のための併用免疫療法 |
| CA3049225A1 (en) | 2017-01-04 | 2018-07-12 | PrimeVax Immuno-Oncology, Inc. | Compositions and methods for therapy with dengue virus |
| US11779599B2 (en) | 2017-11-07 | 2023-10-10 | Coimmune, Inc. | Methods and uses for dendritic cell therapy |
| CN111166876B (zh) * | 2018-11-13 | 2022-10-11 | 北京启辰生生物科技有限公司 | 一种免疫增强剂组合和编码核酸及其应用 |
| KR102698871B1 (ko) * | 2021-09-10 | 2024-08-28 | 이종균 | 수지상 세포, 자연 살해 세포 및 세포 독성 t 세포를 포함하는 암의 예방 또는 치료용 생물학적 조성물 |
| WO2024231621A1 (fr) * | 2023-05-05 | 2024-11-14 | Centre National De La Recherche Scientifique | Acide nucleique synthetique et ses utilisations therapeutiques |
Family Cites Families (46)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0411228B1 (en) | 1989-07-31 | 1995-11-08 | International Business Machines Corporation | Controlled fiber-optic switch |
| US5936076A (en) | 1991-08-29 | 1999-08-10 | Kirin Beer Kabushiki Kaisha | αgalactosylceramide derivatives |
| US7405270B2 (en) | 1991-10-25 | 2008-07-29 | Immunex Corporation | CD40-Ligand lacking native-pattern glycosylation |
| US5962406A (en) | 1991-10-25 | 1999-10-05 | Immunex Corporation | Recombinant soluble CD40 ligand polypeptide and pharmaceutical composition containing the same |
| US5981724A (en) | 1991-10-25 | 1999-11-09 | Immunex Corporation | DNA encoding CD40 ligand, a cytokine that binds CD40 |
| CA2121798C (en) | 1991-10-25 | 2007-07-24 | Richard J. Armitage | Novel cytokine |
| TW261533B (enExample) | 1992-07-16 | 1995-11-01 | Kirin Brewery | |
| KR100281264B1 (ko) | 1992-10-22 | 2001-02-01 | 마나배 게이사꾸 | 신규한 스핀고당 지질 및 그의 사용 |
| CN1045302C (zh) | 1993-04-15 | 1999-09-29 | 麒麟麦酒株式会社 | 新型(神经)鞘糖脂、含有它们的药物组合物及其用途 |
| PL181496B1 (pl) | 1996-03-20 | 2001-07-31 | Politechnika Slaska Im Wincent | Sposób wytwarzania ß-naftolu PL |
| AU705647B2 (en) | 1996-07-10 | 1999-05-27 | Immunex Corporation | Method of activating dendritic cells |
| US6017527A (en) | 1996-07-10 | 2000-01-25 | Immunex Corporation | Activated dendritic cells and methods for their activation |
| TW555562B (en) | 1996-12-27 | 2003-10-01 | Kirin Brewery | Method for activation of human antigen-presenting cells, activated human antigen-presenting cells and use thereof |
| ES2235324T3 (es) | 1997-04-10 | 2005-07-01 | Kirin Beer Kabushiki Kaisha | Empleo de a-glicosilceramidas para la obtencion de un agente terapeutico para enfermedades autoinmunes. |
| TW575420B (en) | 1997-09-22 | 2004-02-11 | Kirin Brewery | Composition for enhancing cellular immunogenicity comprising alpha-glycosylceramides |
| ATE428769T1 (de) | 1997-10-27 | 2009-05-15 | Univ Rockefeller | Methode und zusammensetzung zur herstellung von reifen dendritischen zellen |
| CA2328604A1 (en) | 1998-05-26 | 1999-12-02 | Andrew Segal | Compositions and methods of modulating an immune response to an antigen |
| EP1185627A2 (en) | 1999-06-01 | 2002-03-13 | Cornell Research Foundation, Inc. | Activation of dendritic cells to enhance immunity |
| US20030077263A1 (en) | 1999-10-29 | 2003-04-24 | Immunex Corporation | Method of activating dendritic cells |
| US20030059427A1 (en) | 2000-04-28 | 2003-03-27 | Force Walker R. | Isolation and characterization of highly active anti-CD40 antibody |
| US7063845B2 (en) | 2000-04-28 | 2006-06-20 | Gemini Science, Inc. | Human anti-CD40 antibodies |
| ES2389645T3 (es) | 2000-06-19 | 2012-10-30 | Beth Israel Deaconess Medical Center | Composiciones y métodos de anticuerpos monoclonales y policlonales específicos para subpoblaciones de linfocitos T |
| AU2001268564A1 (en) | 2000-06-22 | 2002-01-02 | The Brigham And Women's Hospital, Inc. | Alpha-glycosylceramides for treating bacterial and fungal infections |
| DE10041515A1 (de) | 2000-08-24 | 2002-03-14 | Gerold Schuler | Verfahren zur Herstellung gebrauchsfertiger, Antigen-beladener oder -unbeladener, kryokonservierter reifer dendritischer Zellen |
| US20040247563A1 (en) | 2000-11-02 | 2004-12-09 | Lynch David H. | Method of enhancing lymphocyte-mediated immune responses |
| AU2002224851A1 (en) | 2000-11-14 | 2002-05-27 | Universite Libre De Bruxelles | Generation and use of dendritic cells |
| JP2004520033A (ja) | 2001-01-15 | 2004-07-08 | イ・デ・エム・イミュノ−デジネ・モレキュル | 分化拘束された成熟樹状細胞の調製用補助組成物 |
| WO2002074345A2 (en) | 2001-03-16 | 2002-09-26 | Johns Hopkins University School Of Medicine | Immune modulation by transduced hematopoietic stem cells expressing antigens and antigen-presenting cell regulatory molecules |
| EP1270732A1 (en) | 2001-06-21 | 2003-01-02 | Schuler, Gerold | Improved transfection of eukaryontic cells with linear polynucleotides by electroporation |
| WO2003010301A1 (en) | 2001-07-25 | 2003-02-06 | I.D.M. Immuno-Designed Molecules | New isolated dendritic cells, a process for preparing the same and their use in pharmaceutical compositions |
| CA2453880A1 (en) | 2001-07-25 | 2003-02-06 | New York University | Use of glycosylceramides as adjuvants for vaccines against infections and cancer |
| DK1437358T3 (da) | 2001-08-16 | 2007-02-05 | Daiichi Asubio Pharma Co Ltd | Hidtil ukendt glycolipid og medikament til autoimmune sygdomme indeholdende dette som det aktive stof |
| EP1444330A1 (en) | 2001-11-07 | 2004-08-11 | Kirin Beer Kabushiki Kaisha | Expansion of t cells in vitro and expanded t cell populations |
| CA2493690C (en) | 2002-06-13 | 2011-11-08 | New York University | Synthetic c-glycolipid and its use for treating cancer, infectious diseases and autoimmune diseases |
| EP1572228A4 (en) | 2002-09-19 | 2009-03-04 | Centocor Inc | METHOD FOR THE INTRODUCTION OF THE TREATMENT OF DENDRITIC CELLS AND ITS USES |
| WO2004026318A1 (ja) | 2002-09-20 | 2004-04-01 | Kirin Beer Kabushiki Kaisha | α-グリコシルセラミドを有効成分とするC型肝炎ウイルス抑制剤 |
| US20040146948A1 (en) * | 2002-10-18 | 2004-07-29 | Centenary Institute Of Cancer Medicine And Cell Biology | Compositions and methods for targeting antigen-presenting cells with antibody single-chain variable region fragments |
| WO2004053095A2 (en) * | 2002-12-10 | 2004-06-24 | Merix Bioscience, Inc. | In situ maturation of dendritic cells |
| SE0301109D0 (sv) | 2003-04-14 | 2003-04-14 | Mallen Huang | Nucleotide vaccine composition |
| US20050003533A1 (en) | 2003-05-08 | 2005-01-06 | Pawel Kalinski | Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use |
| AU2004277376B2 (en) | 2003-07-18 | 2011-06-02 | Eastern Virginia Medical School | Apparatus for generating electrical pulses and methods of using the same |
| CN1882603A (zh) | 2003-11-25 | 2006-12-20 | 阿哥斯医疗公司 | mRNA转染的抗原呈递细胞 |
| US20050222048A1 (en) | 2004-03-31 | 2005-10-06 | The Research Foundation Of The City University Of New York | Novel synthetic C-glycolipids, their synthesis and use to treat infections, cancer and autoimmune diseases |
| KR101243577B1 (ko) | 2004-10-07 | 2013-03-20 | 아고스 쎄라퓨틱스, 인코포레이티드 | 성숙 수지상 세포 조성물 및 그의 배양 방법 |
| US8513008B2 (en) | 2004-10-07 | 2013-08-20 | Argos Therapeutics, Inc. | Mature dendritic cell compositions and methods for culturing same |
| JP5020935B2 (ja) * | 2005-04-08 | 2012-09-05 | アルゴス セラピューティクス,インコーポレイティド | 樹状細胞組成物および方法 |
-
2006
- 2006-04-07 US US11/400,774 patent/US8513008B2/en not_active Expired - Fee Related
-
2007
- 2007-04-06 KR KR1020087024226A patent/KR101425686B1/ko not_active Expired - Fee Related
- 2007-04-06 WO PCT/US2007/008734 patent/WO2007117682A2/en not_active Ceased
- 2007-04-06 US US12/226,092 patent/US20120269832A1/en not_active Abandoned
- 2007-04-06 JP JP2009504346A patent/JP5425618B2/ja not_active Expired - Fee Related
- 2007-04-06 AT AT07755113T patent/ATE510451T1/de active
- 2007-04-06 DK DK07755113.3T patent/DK2003969T3/da active
- 2007-04-06 AU AU2007235227A patent/AU2007235227B2/en not_active Ceased
- 2007-04-06 CA CA2648675A patent/CA2648675C/en active Active
- 2007-04-06 CN CN200780020901.5A patent/CN101460054B/zh not_active Expired - Fee Related
- 2007-04-06 EP EP07755113A patent/EP2003969B1/en active Active
-
2013
- 2013-07-15 US US13/941,627 patent/US9523077B2/en not_active Expired - Fee Related
-
2016
- 2016-12-19 US US15/383,574 patent/US10184108B2/en not_active Expired - Lifetime
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009533025A5 (enExample) | ||
| JP2008515439A5 (enExample) | ||
| ATE510451T1 (de) | Zusammensetzungen mit reifen dendritischen zellen und verfahren zu ihrer kultivierung | |
| AU2016335029B2 (en) | 3' UTR sequences for stabilization of RNA | |
| DE602005025005D1 (de) | Zusammensetzungen reifer dendritischer zellen und verfahren zu deren kultivierung | |
| JP2009506762A5 (enExample) | ||
| BRPI0212545B8 (pt) | método ex vivo ou in vitro para produzir uma população de célula dendrítica madura e método para produzir células t | |
| JP2004267216A5 (enExample) | ||
| HRP20110981T1 (hr) | Tumoru pridruženi peptidi koji se slobodno vežu na molekule ljudskog leukocitnog antigena (hla) klasa ii | |
| JP2005505270A5 (enExample) | ||
| JP2004531242A5 (enExample) | ||
| JP2007504810A5 (enExample) | ||
| JPWO2021219897A5 (enExample) | ||
| JP2010538649A5 (enExample) | ||
| JP2005523681A5 (enExample) | ||
| JP7416686B2 (ja) | 体細胞を再プログラムするためのrnaレプリコン | |
| CA3074919A1 (en) | Rna replicon for expressing a t cell receptor or an artificial t cell receptor | |
| EP1913954B1 (en) | Use of the eda domain of fibronectin | |
| AU2025204247A1 (en) | Large and small T antigens of merkel cell polyomavirus, nucleic acid constructs and vaccines made therefrom, and methods of using same | |
| JP2003530821A5 (enExample) | ||
| CA3040035A1 (en) | Nucleotide sequence expressing an exosome-anchoring protein for use as vaccine | |
| JP2011507515A5 (enExample) | ||
| JP2002516662A5 (enExample) | ||
| WO2001068829A3 (en) | Genetically stable cholera vaccines | |
| US20150040254A1 (en) | Porcine CD28 receptor, gene for encoding same, and application of same |